New Zealand markets closed

Stryker Corporation (SYK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
249.27-2.65 (-1.05%)
At close: 04:03PM EST
251.00 +1.73 (+0.69%)
After hours: 07:56PM EST

Stryker Corporation

2825 Airview Boulevard
Kalamazoo, MI 49002
United States
269 385 2600

IndustryMedical Devices
Full-time employees43,000

Key executives

NameTitlePayExercisedYear born
Mr. Kevin A. LoboChairman, CEO & Pres2.97M8.91M1965
Mr. Glenn S. BoehnleinVP & CFO1.28MN/A1962
Mr. Robert S. FletcherVP & Chief Legal Officer895.89kN/A1971
Mr. Viju S. MenonGroup Pres of Global Quality & Operations1.15MN/A1968
Mr. William E. Berry Jr.VP & Chief Accounting OfficerN/AN/A1966
Mr. Robert C. CohenCTO and VP of Global R&D - Joint ReplacementN/AN/AN/A
Mr. Alan DouvilleVP, Chief Information Officer & Chief Information Security OfficerN/AN/AN/A
Mr. Preston WellsVP of Investor RelationsN/AN/AN/A
Ms. Dana S. McMahonVP & Chief Compliance OfficerN/AN/AN/A
Ms. M. Kathryn FinkVP & Chief HR OfficerN/AN/A1970
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Corporate governance

Stryker Corporation’s ISS governance QualityScore as of 26 September 2021 is 5. The pillar scores are Audit: 9; Board: 7; Shareholder rights: 4; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.